RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work By ONCY shifting gears into Cantor Fitzgerald, a US based global financial institution with world-class specialized talent with a particular focus on healthcare, biopharmaceuticals, and technology, ONCY throws the doors open to opportunites that the Accelerated Approval pathway can bring for ONCY's pelareorep in combination with paclitaxel for the treatment of HR+/HER2- metastatic Breast Cancer used in 2 different scenarios- (1) either prior to (in ADC intolerant) which was originally planned before ADC therapy, or (2) following ADC therapy (in ADC failure), AND for pelareorep in combination with an immune checkpoint inhibitor for the treatment of pancreatic cancer (PDAC), at a time when the markets are shifting into small cap stocks and Big Pharma is ramping up their M&A activities.